All Stories

  1. Smoking and medication-overuse headache: Exploring the potential link between nicotine dependence and analgesic overuse
  2. Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021
  3. Headache with Neurological Deficits and CSF Lymphocytosis (HaNDL Syndrome)
  4. Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  5. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  6. Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials
  7. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
  8. Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021
  9. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  10. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  11. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
  12. GBD 2023 Cardiovascular Disease Collaborators
  13. GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis
  14. Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity
  15. Secondary Macular Hole Closure With Sub-Tenon Triamcinolone Acetonide
  16. Reliability and validity of the Arabic version of cluster headache impact questionnaire in both active episodic and chronic cluster headache
  17. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  18. Efficacy of robotic training gloves in improving hand function and movement in stroke patients
  19. Multimodal diagnostic tools and advanced data models for detection of prodromal Parkinson’s disease: a scoping review
  20. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  21. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  22. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  23. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
  24. Epilepsy Arabic renaming to cerebroelectric disorder could minimize the stigma
  25. Validity, reliability, and sensitivity to change of the Arabic version of the Migraine‐Specific Quality‐of‐Life Questionnaire after prophylactic treatment
  26. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  27. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
  28. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
  29. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  30. Unveiling the retinal secrets of neuromyelitis optica spectrum disorder
  31. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  32. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  33. Burden of disease scenarios for 204 countries
  34. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  35. Reliability, validity, and responsiveness of the Arabic version of HIT ‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study
  36. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  37. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  38. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  39. Validity and reliability of Arabic version of pediatric migraine disability assessment scale (Child Self-Report versus Parent Proxy-Report): a multi-center study
  40. The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case–control study
  41. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  42. Vision Impairment prediction for patients diagnosed with Multiple Sclerosis: Cosmos based machine learning model training and evaluation
  43. Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  44. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  45. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  46. Clinical Predictors of Transation to Secondary Progressive Multiple Sclerosis
  47. Neutrophil-to-Lymphocyte Ratio: a Marker of Neuro-inflammation in Multiple Sclerosis Patients: a Meta-analysis and Systematic Review
  48. Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019–2020: randomized controlled clinical trial
  49. Amelioration of bioavailability through formulating and optimizing Azilsartan Entrapped nanostructured lipid carriers and its pharmacokinetic assessment
  50. Comparative study of the anti-diabetic effect of mucilage and seed extract of Abelmoschus esculentus against streptozotocin-induced diabetes in rat model
  51. Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
  52. Lagerstroemia speciosa Ameliorated Blood Pressure in LNAME Induced Hypertension in Experimental Rats through NO/cGMP and Oxidative Stress Modulation
  53. An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
  54. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  55. Nanotechnological Advances in the Treatment of Epilepsy
  56. Board Walk
  57. Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  58. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  59. Helicobacter pylori infection in migraine headache: A true association or an innocent bystander?
  60. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  61. Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study
  62. In Vitro Evaluation of Antibacterial, Antioxidant, and Antidiabetic Activities and Glucose Uptake through 2‐NBDG by Hep‐2 Liver Cancer Cells Treated with Green Synthesized Silver Nanoparticles
  63. Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study
  64. Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study
  65. The MuSC-19 study: The Egyptian cohort
  66. Mapping Anemia in Women: Global Trends and Inequality
  67. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  68. Behavior and awareness of multiple sclerosis patients during COVID-19 pandemic in a tertiary center in Egypt
  69. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels
  70. Zinc deficiency correlates with severity of diabetic polyneuropathy
  71. Child Mortality Trends and Targets: GBD 2019 Findings
  72. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  73. Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case–Control Study
  74. Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect
  75. Bovine mastitis prevention and control in the post-antibiotic era
  76. lincR-Ccr2-5′AS and THRIL as potential biomarkers of multiple sclerosis
  77. The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
  78. Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report
  79. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  80. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  81. The potential role of 2D-speckle tracking echocardiography for detecting left ventricular systolic dysfunction in patients with Parkinson’s disease: a case control study
  82. Five insights from the Global Burden of Disease Study 2019
  83. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  84. FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis
  85. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era
  86. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  87. Crystal Growth and Kinetic Behaviour of Pseudoalteromonas espejiana Assisted Biosynthesized Gold Nanoparticles
  88. Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
  89. Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
  90. Glutamate and Nitric Oxide as biomarkers for disease activity in patients with multiple sclerosis
  91. Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
  92. Thalamic Involvement and its Impact on Disability and Cognition in Multiple Sclerosis: A Clinical and Diffusion Tensor Imaging Study
  93. Assessment of School-Aged Children of Mothers With Idiopathic Generalized Epilepsy
  94. Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis
  95. Foot-and-mouth disease vaccines: recent updates and future perspectives
  96. Proprioception Errors in Patients with Cervical Spondylosis at Sagittal Plane
  97. Diffusivity Parameters as Markers for NAGM Involvement and Disease Progression in MS Patients: Diffusion Tensor Imaging Study
  98. Testing of Verbal Fluency in Egyptians
  99. Role of concentric needle Single Fiber Electromyography in detection of subclinical motor involvement in carpal tunnel syndrome
  100. Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
  101. Objective pain assessment by electrical stimulation
  102. Clinical, diffusion tensor imaging, and cognitive biomarkers of seizure control in patients with juvenile myoclonic epilepsy
  103. Verbal fluency tests in Egyptians: Cultural and educational challenges
  104. P295 Effects of functional electric stimulation and task specific training on gait recovery in patients with stroke: Randomized controlled trial
  105. Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
  106. Urinary 6-Sulphatoxymelatonin Levels and Sleep Disorders in Children With Migraine